CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...